Skip to Content

Coronavirus information for Feinberg.

Download the full-sized PDF of Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient
Download the file

Actions

Download Analytics Citations

Export to: EndNote

Collections

This file is not currently in any collections.

Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient Open Access (recommended)

Descriptions

Resource type(s)
Article
Keyword
TTP
HUS
thrombotic microangiopathy
Rights
Attribution 4.0 International

Creator
Gordon, Leo I
Kwaan, Hau C
Abstract
The complication of thrombotic thrombocytopenic purpura or hemolytic uremic syndrome (TTP/HUS) can occur in cancer patients. It is characterized by a microangiopathic hemolytic anemia, severe thrombocytopenia, and renal failure. Pulmonary manifestations, especially pulmonary edema, are a common observation. Neurologic changes are also frequently seen. The etiology is unknown at this time. It has been observed in many different types of cancer and is most commonly seen in gastric adeno-carcinoma followed by carcinoma of the breast, colon, and small cell lung carcinoma. The hemolysis can be massive and is due to red cell fragmentation, as schistocytes are present in all the cases. Though immune complexes are present in the plasma, the antiglobulin (Coomb's) test is negative. Chemotherapeutic agents, especially mitomycin C, have been implicated as causative factors. There is a correlation of this complication with the cumulative dose. However, chemotherapy cannot account for all the cases as the syndrome can occur in untreated patients. It can be differentiated from disseminated intravascular coagulation by the absence of a coagulopathy. Management should consist of plasma exchange, use of a Staphyloccus aureus column (Prosorba), and control of hypertension. Because of the susceptibility to pulmonary edema, blood volume overloading should be avoided.
Original Bibliographic Citation
Gordon, L. I., & Kwaan, H. C. (1999). Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost, 25(2), 217-221. doi:10.1055/s-2007-994923
Publisher
Thieme Medical Publishers, Inc.
DigitalHub. Galter Health Sciences Library
Date Created
1999
Original Identifier
(PMID) 10357089
Language
English
Subject: MESH
Purpura, Thrombotic Thrombocytopenic
Hemolytic-Uremic Syndrome
Neoplasms
Hemolysis
DOI
10.1055/s-2007-994923
ARK
ark:/c8131/g3qw3f

File Details

File Properties
Mime type: application/pdf
File size: 5312.2 kB